QQQ   265.19 (-1.89%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
QQQ   265.19 (-1.89%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
QQQ   265.19 (-1.89%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
QQQ   265.19 (-1.89%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
Log in

OTCMKTS:RCDTFRecordati Stock Price, Forecast & News

$53.27
0.00 (0.00 %)
(As of 08/12/2020 04:00 PM ET)
Add
Compare
Today's Range
$53.27
Now: $53.27
$53.27
50-Day Range
$47.56
MA: $51.60
$55.80
52-Week Range
$36.50
Now: $53.27
$55.80
Volume85 shs
Average Volume1,584 shs
Market Capitalization$11.14 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.45
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals in Europe, the Middle East, Africa, the United States, Canada, and internationally. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, cosmetics, dermatology, dietary supplements, gynecology and obstetrics, medical devices, musculo-skeletal disorders and analgesia, over the counter/non-prescription pharmaceuticals, urology, allergy, anti-infectives, central nervous system, endocrinology, gastrointestinal, nutrition and related products, immune-suppressants, pain management/inflammation, generics, pneumology, antipyretics and cold preparations, endocrinology, oncology, respiratory, and radio contrast agent, as well as ear, nose, and throat. It also provides pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.59 out of 5 stars


Industry, Sector and Symbol

Industry Private households
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:RCDTF
Previous SymbolNASDAQ:RCDTF
CUSIPN/A
CIKN/A
Phone390-248-7871

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.60 billion
Cash Flow$2.09 per share
Book Value$5.44 per share

Profitability

Miscellaneous

Employees4,142
Market Cap$11.14 billion
Next Earnings Date8/18/2020 (Estimated)
OptionableNot Optionable
$53.27
0.00 (0.00 %)
(As of 08/12/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive RCDTF News and Ratings via Email

Sign-up to receive the latest news and ratings for RCDTF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Recordati (OTCMKTS:RCDTF) Frequently Asked Questions

How has Recordati's stock price been impacted by Coronavirus?

Recordati's stock was trading at $40.40 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, RCDTF shares have increased by 31.9% and is now trading at $53.2696.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Recordati?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Recordati in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Recordati
.

When is Recordati's next earnings date?

Recordati is scheduled to release its next quarterly earnings announcement on Tuesday, August 18th 2020.
View our earnings forecast for Recordati
.

Has Recordati been receiving favorable news coverage?

Headlines about RCDTF stock have been trending somewhat negative on Wednesday, according to InfoTrie. The research group rates the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Recordati earned a news impact score of -1.2 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future.
View the latest news about Recordati
.

Are investors shorting Recordati?

Recordati saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 31,500 shares, a decrease of 26.7% from the April 15th total of 43,000 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is currently 315.0 days.
View Recordati's Short Interest
.

Who are some of Recordati's key competitors?

Who are Recordati's key executives?

Recordati's management team includes the following people:
  • Mr. Andrea Recordati, CEO & Director (Age 48)
  • Mr. Fritz Squindo, CFO, MD & Exec. Director (Age 63)
  • Ms. Marianne Tatschke, Director of Investor Relations & Corp. Communications
  • Ms. Daria Ghidoni, Director of Legal Affairs & Group Companies
  • Mr. Gabriele Finzi, VP & Director Corp. Devel.

What is Recordati's stock symbol?

Recordati trades on the OTCMKTS under the ticker symbol "RCDTF."

How do I buy shares of Recordati?

Shares of RCDTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Recordati's stock price today?

One share of RCDTF stock can currently be purchased for approximately $53.27.

How big of a company is Recordati?

Recordati has a market capitalization of $11.14 billion and generates $1.60 billion in revenue each year. Recordati employs 4,142 workers across the globe.

What is Recordati's official website?

The official website for Recordati is www.recordati.com.

How can I contact Recordati?

Recordati's mailing address is Via Matteo Civitali 1, Milano L6, 20148. The company can be reached via phone at 390-248-7871 or via email at [email protected]

This page was last updated on 8/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.